Brethon, B., Lainey, E., Caye-Eude, A., Grain, A., Fenneteau, O., Yakouben, K., . . . Baruchel, A. (2021). Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia. Front Oncol.
Chicago Style CitationBrethon, Benoît, et al. "Case Report: Targeting 2 Antigens As a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia." Front Oncol 2021.
MLA CitationBrethon, Benoît, et al. "Case Report: Targeting 2 Antigens As a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia." Front Oncol 2021.